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Kastner C, Pohl M, Sendeski M, Stange G, Wagner CA,
Jensen B, Patzak A, Bachmann S, Theilig F. Effects of receptor-
mediated endocytosis and tubular protein composition on volume
retention in experimental glomerulonephritis. Am J Physiol Renal
Physiol 296: F902–F911, 2009. First published February 4, 2009;
doi:10.1152/ajprenal.90451.2008.—Human glomerulonephritis (GN)
is characterized by sustained proteinuria, sodium retention, hyperten-
sion, and edema formation. Increasing quantities of filtered protein
enter the renal tubule, where they may alter epithelial transport
functions. Exaggerated endocytosis and consequent protein overload
may affect proximal tubules, but intrinsic malfunction of distal epi-
thelia has also been reported. A straightforward assignment to a
particular tubule segment causing salt retention in GN is still contro-
versial. We hypothesized that 1) trafficking and surface expression of
major transporters and channels involved in volume regulation were
altered in GN, and 2) proximal tubular endocytosis may influence
locally as well as downstream expressed tubular transporters and
channels. Effects of anti-glomerular basement membrane GN were
studied in controls and megalin-deficient mice with blunted proximal
endocytosis. Mice displayed salt retention and elevated systolic blood
pressure when proteinuria had reached 10–15 mg/24 h. Surface
expression of proximal Na-coupled transporters and water channels
was in part [Na-Pi cotransporter IIa (NaPi-IIa) and aquaporin-1
(AQP1)] increased by megalin deficiency alone, but unchanged
(Na/H exchanger 3) or reduced (NaPi-IIa and AQP1) in GN
irrespective of the endocytosis defect. In distal epithelia, significant
increases in proteolytic cleavage products of -epithelial Na channel
(ENaC) and -ENaC were observed, suggesting enhanced tubular
sodium reabsorption. The effects of glomerular proteinuria dominated
over those of blunted proximal endocytosis in contributing to ENaC
cleavage. Our data indicate that ENaC-mediated sodium entry may be
the rate-limiting step in proteinuric sodium retention. Enhanced pro-
teolytic cleavage of ENaC points to a novel mechanism of channel
activation which may involve the action of filtered plasma proteases.
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PROTEINURIA IS A CLINICAL hallmark of acute and chronic glo-
merular diseases. Under normal conditions, glomerular perm-
selectivity is believed to retain most serum proteins. Only
minor quantities especially of albumin are thus passing through
the filter to be retrieved by the proximal tubule via receptor-
mediator endocytosis (RME), requiring the multiligand recep-
tors megalin and cubilin (15). Proteins are subsequently deliv-
ered to the lysosomes, degraded, and finally delivered to the
peritubular blood. In nephrotic range proteinuria, substantially
more protein is filtered through the damaged glomeruli owing
to the general increase in fractional filtration of macromole-
cules. The resulting high tubular protein concentration leads to
saturation of the receptors and exceeds the retrieval and deg-
radation capacity of the proximal tubule, causing cellular protein
overload and proteinuria. Interstitial edema, renal salt and water
retention, and hypertension occur consequently (17, 35, 42).
The potential causes for these disorders have been only partly
elucidated to date.
Salt retention in nephrosis has commonly been explained by
the hypovolemia concept, implying decreased oncotic pressure
following proteinuria, loss of fluid into the interstitium, and
subsequent activation of the renin-angiotensin-aldosterone sys-
tem (RAAS) (18, 32). However, volume disorders in nephrotic
patients may also occur without concomitant changes in blood
pressure and effects of the RAAS (3, 38). It has therefore been
discussed that primary tubular salt retention may per se lead to
volume expansion (“circulatory overfilling”) (27, 42).
In the search for potential sites of sodium retention along the
renal tubule, the proximal tubule has been a focus (1, 4, 24, 34,
51). Protein overload may impair its structure, causing cy-
toskeletal changes, lipids may become accumulated, and in-
flammatory factors can be induced. As a result, trafficking of
transporters and channels may be impaired (22, 32, 40).
Na/H exchanger 3 (NHE3)-dependent sodium reabsorption
and lysosomal acidification may be affected (7, 32, 34), and
coexpressed transport proteins such as aquaporin-1 (AQP1)
and the Na-Pi cotransporter IIa (NaPi-IIa) may be involved (22).
Distally, regulation of the Na-K-2Cl-cotransporter 2
(NKCC2) of thick ascending limbs (TAL) of Henle’s loop may
be affected as well (32), but the major distal site of retention
has formerly been assigned to the collecting ducts (6, 29), and
recent work has been concentrated on the activation of the
epithelial Na channel (ENaC) in a RAAS-independent way
(3, 33, 38). New perspectives have also come from observa-
tions that ENaC subunits are cleaved by proteases, which may
increase the open probability of the channel (3, 5, 13, 21, 22,
25, 28, 43, 48; for a review, see also Ref. 44).
The aim of this study was to specify possible tubular causes
for volume disorders in rapid-progressive, immune-mediated
glomerulonephritis (GN) under controlled proteinuria which
was clearly below nephrotic range. Changes at the level of
the proximal and distal nephron epithelia were analyzed. We
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hypothesized that 1) trafficking and surface expression of the
major tubular transport proteins involved in volume regulation
were altered in GN, and 2) proximal tubular RME with respect
to its high protein reabsorptive capacity may influence locally
as well as downstream expressed tubular transporters and
channels. To this end, an established mouse model for anti-
glomerular basement membrane (GBM) GN, induced in a
kidney-specific, megalin-deficient transgenic strain (36, 51),
was used. The partial (50–70%) absence of a functioning,
megalin/cubilin-mediated endocytotic apparatus in this strain
permits the side-by-side analysis of megalin-deficient and in-
tact proximal tubules for histological analysis and causes
low-molecular-weight proteinuria (36). This constellation was
used to define the proximal and distal phenotypes of the
membrane transporters in GN-grade glomerular proteinuria,
with supplementary implications from tubular proteinuria.
METHODS
Animals and treatments. Experiments were performed in female
conditional megalin knockout mice (megalin lox/lox; apoE Cre) (51),
here termed Cre(), and in controls (megalin lox/lox), termed
Cre(); body weight 20–30 g, age 12–15 wk. Remnant megalin
expression in Cre() was verified by sampling of the urinary vitamin
D binding protein levels (36). Mice [n  25; 12 Cre() mice and 13
Cre() mice] were immunologically primed by subcutaneous injec-
tion of rabbit IgG in complete Freund’s adjuvant. GN was induced 6
days later by the intravenous injection of an anti-mouse GBM serum
(47) in six Cre() and seven Cre() mice, whereas six mice of each
strain received an injection of vehicle. The mice were killed when
proteinuria had reached 10–15 mg/24 h, and control animals were
killed in parallel. Mice were allowed free access to standard chow and
tap water. For urine analysis, mice were individually placed in
metabolic cages for 24 h before day 0 and every week starting from
day 12 of the experiment. The experiments were conducted in accor-
dance to the German Law for the protection of animals (Reg G
0178/03).
Blood and urine analyses. Electrolytes in serum and urine were
determined by indirect ion-selective electrode measurements (Modu-
lar Analytics, Roche Diagnostics, Mannheim, Germany), and urinary
osmolality was measured with an osmometer (Gonotec, Berlin, Ger-
many). Blood urea nitrogen (BUN) and creatinine concentrations were
quantified enzymatically and by the kinetic Jaffe´-method (Modular
Analytics, Roche Diagnostics). Creatinine clearance and fractional
sodium excretion were calculated using standard equations. Total
protein concentration in serum and urine as well as albumin, choles-
terol, and triglyceride levels in serum were measured with standard-
ized autoanalyzer methods (Hitachi 747, Hitachi 911, and STA
analyzers; Roche Diagnostics).
Hemodynamic measurements. At the end of the experiment, cath-
eters were inserted into the right femoral artery. Blood pressure
recordings were performed 24 h after surgery in conscious unre-
strained mice. Animals were observed during the recording period,
and recording was stopped once an artifact-free recording of at least
5 min was obtained (47).
Fixation and tissue processing for immunohistochemistry. Mice
were anesthetized by an injection of pentobarbital sodium (0.06 mg/g
body wt ip). Kidneys were then perfused retrogradely through the
abdominal aorta using 3% paraformaldehyde (PFA) as described (51)
for immunohistochemistry or removed, weighed, and shock-frozen for
biochemistry. For cryostat sectioning, tissues were protected from
freezing artifacts by subsequent overnight immersion in PBS adjusted
to 800 mosmol/kgH2O sucrose, shock-frozen, and stored at 80°C.
For the paraffin technique, tissues were postfixed in 3% PFA, dehy-
drated, and standard paraffin-embedded and stored at 20°C.
Tissue processing for immunoblotting. For isolation of cortical
brush border membrane (BBM), the kidney cortex was homogenized
in isolation buffer containing 300 mM D-mannitol, 5 mM EGTA, 16
mM HEPES, 10 mM Tris-base, and a protease inhibitor cocktail
(Complete, Roche Diagnostics) as described (4). For the isolation of
cortical and medullary membrane fractions, tissue was homogenized
in sucrose buffer containing 250 mM sucrose, 10 mM triethanol-
amine, and a protease inhibitor cocktail (Complete) and centrifuged to
obtain the plasma membrane fraction. Total protein concentration was
measured using the Pierce BCA Protein Assay reagent kit (Pierce,
Rockford, IL) and controlled by Coomassie staining.
Gel electrophoresis and SDS-PAGE. After Laemmli’s sample
buffer was added, the proteins were solubilized at 96°C for 3 min.
SDS gel electrophoresis was performed on 8–10% polyacrylamide
gels. After electrophoretic transfer of the proteins to nitrocellulose
membranes, equity in protein loading and blotting was verified by
membrane staining using 0.1% Ponceau red. Membranes were probed
overnight at 4°C with primary antibodies and then exposed to horse-
radish peroxidase-conjugated secondary antibodies (DAKO, Ham-
burg, Germany). Immunoreactive bands were detected on the basis of
chemiluminescence, using an enhanced chemiluminescence kit (Am-
ersham Pharmacia, Freiburg, Germany) before exposure to X-ray
films (Hyperfilm, Amersham). For densitometric evaluation of the
resulting bands, films were scanned and analyzed using BIO-PROFIL
Bio-1D image software (Vilber Lourmat, Marne-La-Valle´e, France).
All parameters had been normalized to -actin abundance.
Antibodies. We used previously well-characterized antibodies: rab-
bit anti-AQP1 (BD Biosciences), monoclonal mouse anti-NHE3
(Chemicon International), rabbit anti-NaPi-IIa, raised against an NH2-
terminal peptide sequence; guinea pig anti-megalin (generated against
a COOH-terminal peptide), monoclonal mouse anti -actin (Sigma,
Deisenhofen, Germany), rabbit anti-AQP2 (gift from E. Klussmann),
monoclonal mouse anti-1-subunit of Na-K-ATPase (-NKA;
Upstate Biotechnology), guinea pig anti-NKCC2 (generated against
an NH2-terminal peptide sequence); and -, -, and -subunits of
ENaC (sera produced against NH2-terminal glutathione-S-transferase
protein of the -subunit and COOH-terminal glutathione-S-trans-
ferase proteins of - and -subunits of ENaC), rabbit anti-cyclooxy-
genase-2 (COX-2; Cayman Chemical), and rabbit anti-renin (gift of
A. Kurtz).
Immunohistochemistry. Immunohistochemical staining was per-
formed on cryostat or on paraffin sections. Sections were blocked with
5% skim milk/PBS, incubated with the respective primary antibody
(see antibodies listed above), followed by incubation with suitable
horseradish peroxidase-coupled secondary antibodies (DAKO) or cy-
3-coupled secondary antibodies (Dianova, Hamburg, Germany). In
double-labeling techniques, the different primary antibodies were
administered consecutively. Specificity of the double-staining proce-
dures was controlled by parallel incubation of consecutive sections,
each incubated only with one single probe. Sections were counter-
stained and analyzed using a Leica DMRB microscope or multilaser
confocal scanning microscope (TCS SP-2, Leica Microsystems, Ben-
sheim, Germany).
RNA isolation, reverse transcription, and real-time PCR. Total
RNA was extracted from kidney cortices using an RNeasy Mini kit
(Qiagen, Hilden, Germany) and treated with DNase I (Invitrogen).
Reverse transcription was performed with the Super-Script First-
Strand Synthesis System for RT-PCR (Invitrogen). TaqMan Gene
Expression Assays were used, and the product IDs for the candidate
genes are Mm00431834_m1 (AQP1), Mm01352473_m1 (NHE3),
and Mm00441450_m1 (NaPi-IIa). The experiment was performed
according to the manual provided by Applied Biosystems (Foster
City, CA).
NHE activity measurements. NHE activity was determined in BBM
vesicles by the acridine orange technique as described (11). Measure-
ments were performed in a Shimadzu RF-5000 spectrofluometer
equipped with a thermostatized cuvette (kept at 25°C). BBM vesicles
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were dissolved in a buffer containing 280 mM mannitol, 5 mM Mes,
and 2 mM MgCl2 (adjusted to pH 5.5 with N-methyl-D-glucamine).
Acridine orange was excited at 493 nm, and emission was monitored
at 530 nm. The cuvette was filled with 2 ml of buffer (240 mM
mannitol/20 mM HEPES/2 mM MgCl2, adjusted to pH 7.5 with
N-methyl-D-glucamine), containing 6 M acridine orange. The exper-
iment was started by injecting 30 l of BBM vesicle suspension. After
60 s of equilibration, NHE activity was initiated by injection of 80 l
of 2 M Na gluconate. NHE activity was calculated as the ratio of pH
per min over Q, where Q is the initial quenching after injection of
BBM vesicles. All experiments were done at least in quadruplicate
and repeated four times with BBM vesicles from two animals per
experiment. To block specifically NHE3, 100 M EIPA was used.
Quantification of COX-2 and renin content. Histochemical signals
were semiquantitatively evaluated with a 	20 and 	40 objective to
establish changes in COX-2 and renin abundance, respectively. The
mean number of renin-positive sites or COX-2-positive macula densa
cells at the juxtaglomerular apparatus was determined within an area
of 100–150 glomeruli on average (49).
Aldosterone assay. Plasma aldosterone was measured with a com-
mercial kit (COAT-A-COUNT, Diagnostic Products). The detection
limit was 13.0 pg/ml, and the intra-assay coefficient of variation
was 
4%.
Presentation of data and statistical analysis. Quantitative data are
presented as means  SE. For statistical comparison, the Mann-
Whitney U-test was employed. P values of 
0.05 were considered
statistically significant, with (*) demonstrating significance between
Cre() and Cre() and (#) between control and GN mice.
RESULTS
Data. Control mice [Cre()] and megalin-deficient mice
[Cre()] as well as control mice with GN [Cre()/GN] and
megalin-deficient mice with GN [Cre()/GN] were compared.
Clinical and renal functional data are presented in Table 1.
Control Cre() mice had significantly elevated urinary protein
excretion owing to the known low-molecular-weight protein-
uria in this strain (36). Application of the nephritogenic anti-
body to Cre() and Cre() induced GN with marked protein-
uria as established earlier (5). All GN mice had been killed
when proteinuria had reached similar levels between strains
and tubulointerstitial changes had not yet developed. Baseline
blood pressure in Cre() was slightly higher than in Cre()
but did not reach significance (90.2  3.6 vs. 78.2  5.5
mmHg; P  0.10). Induction of GN led to significant blood
pressure increases in both strains with a higher tendency
maintained in Cre()[113.3  6.7 in Cre()/GN and 120.3 
6.9 in Cre()/GN; P 
 0.05 intrastrain, P  0.12 interstrain]
(Fig. 1). Tissue COX-2 and renin immunoreactivity levels, as
revealed by juxtaglomerular quantification of histochemical
signals, and plasma aldosterone concentrations showed no
significant differences between groups (Table 2). The frac-
tional sodium excretion was strongly reduced with GN in both
strains (P 
 0.05). Plasma cholesterol levels were increased in
GN. Since Cre() had the characteristic mosaic pattern of
megalin deficiency (4), the degree of megalin knockout was
monitored by Western blotting of BBM, revealing between 50
and 70% megalin deficiency in this strain. Urinary vitamin D
binding protein (DBP) excretion was determined to assess the
influences of proteinuria and megalin-dependent endocytosis
on the tubular handling of this parameter (Fig. 2). As expected,
DBP was significantly increased in megalin deficiency [916 
99% in Cre() vs. 100  32% in Cre(); P 
 0.05]. The
induction of GN caused a marked increase in DBP excretion in
Cre()/GN group (782  111%; P 
 0.05), which was still
more pronounced in the Cre()/GN (1,371  143%; P 

0.05). In sum, RME deficiency alone produced mild protein-
uria. The GN groups were characterized by substantial protein-
Table 1. Clinical parameters
Cre() Cre() Cre()/GN Cre()/GN
General data
Body weight, g 21.4601.34 19.931.11 27.401.85 28.612.00
Kidney weight, g 0.270.05 0.290.03 0.400.04 0.410.10
Systolic blood pressure, mmHg 78.205.47 90.203.55 113.303.00† 120.336.94†
Water consumption, ml 2.220.64 1.540.20 1.420.18 2.080.28
Urinary volume, ml 0.870.08 0.670.19 1.310.23 1.230.22
Plasma parameters
Na, mmol/l 156.5301.78 155.9502.27 153.822.05 164.376.88
K, mmol/l 6.860.93 5.760.53 5.930.87 6.690.55
Cl, mmol/l 120.472.29 121.323.70 117.100.83 121.782.17
Protein, g/l 43.932.72 38.326.25 44.342.14 32.106.90
Albumin, g/l 21.481.80 2.743.71 21.962.07 15.002.75
Creatinine, mol/l 9.401.29 9.672.60 8.002.31 9.133.20
Cholesterol, g/l 1.040.10 1.040.12 1.840.10† 1.690.21†
Triglyceride, g/l 0.470.06 0.430.03 0.500.03 0.420.08
Urea, mmol/l 11.393.45 9.152.99 10.043.21 18.333.98
Osmolality, mosmol/kgH2O 337.4004.36 341.407.61 336.604.62 357.805.30
Renal function
Creatinine clearance GFR, l  min1  g body wt1 10.871.33 11.3601.92 13.601.30 12.600.87
Fractional Na excretion (FE%) 0.200.02 0.310.03 0.120.01† 0.150.01†
Urinary analysis
Na, mol  24 h1  g body wt1 3.210.48 2.490.56 4.490.82 4.760.68
K, mol  24 h1  g body wt1 4.220.51 3.200.59 5.950.68 7.460.95
Cl, mol  24 h1  g body wt1 4.670.71 2.800.75 5.481.20 5.110.99
Protein, g  24 h1  g body wt1 23.703.73 63.758.47* 423.5948.67† 464.9715.79†
Osmolality, mosmol/kgH2O 1,39036 1,563326 1,610130 1,587210
Values are means  SE measured on the last day of the experiment; n  6. Cre(), conditional megalin knockout mice; Cre(), controls; GFR, glomerular
filtration rate; GN, glomerulonephritis. *P 
 0.05 Cre() vs. Cre(). †P 
 0.05 control vs. GN.
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uria, elevated blood pressure, proteinuria, and sodium reten-
tion; RME deficiency only tangentially but not significantly
aggravated these parameters. Juxtaglomerular and RAAS pa-
rameters were unchanged.
Abundances of proximal tubular transporters and AQP1.
Megalin-positive and megalin-deficient proximal tubule cells
were compared side-by-side under control and proteinuric
conditions. Figure 3 demonstrates that the absence of megalin
and associated changes in cell morphology produced no major
changes in NHE3 immunoreactive signals at the base of the
BBM, whereas NaPi-IIa and AQP1 signals were increased
apically in BBM of Cre() compared with Cre(). NHE3
activity, as measured in BBM vesicles using the acridine
orange quenching method, showed no differences between the
control groups; using the NHE3-specific inhibitor EIPA (100
M), total NHE activity was entirely blocked in Cre() and
Cre() alike (Fig. 4). BBM Western blot abundances of
NaPi-IIa and AQP1, but not of NHE3 were higher in Cre()
(Fig. 5A; Table 3), whereas mRNA levels of all three products
were unchanged (Table 4).
The induction of GN produced no changes in proximal
tubular NHE3 immunoreactive signals irrespective of the pres-
ence of megalin (Fig. 3). In contrast, NaPi-IIa and AQP1
signals were markedly decreased in Cre()/GN, and in
Cre()/GN, megalin-positive as well as megalin-negative cells
showed reduced signal intensities compared with Cre(). To-
tal NHE activity in the GN groups was not different from the
controls; however, since blockade by EIPA indicated a signif-
icant reduction of NHE3 activity [44.2  3.1% in Cre() and
42.5  4.9% in Cre(); Fig. 4], yet another NHE activity,
which remained unaffected by EIPA, may have become acti-
vated upon GN induction. These changes were not influenced
by megalin availability. BBM Western blot intensity mostly
paralleled these changes (Fig. 5A; Table 3). Cortical mRNA
levels were unchanged for NHE3, whereas NaPi-IIa and AQP1
showed a reduction in GN that did not depend on megalin
(Table 4).
In aggregate, these results show that cortical NHE3 synthe-
sis and BBM abundance are largely unaffected by proteinuria
as well as megalin-dependent endocytosis, whereas NHE3
activity was reduced in GN. Contrastingly, the abundances of
NaPi-IIa and AQP1 were mostly reduced under GN-associated
proteinuria, even though megalin-deficient cells showed the
established, relative signal enhancement for NaPi-IIa caused
by its impaired retrieval (4), and the same applied to AQP1.
The details of these changes are summarized in Table 5.
Abundances of distal tubular transporters and AQP2. To
study the epithelial effects of GN on transporter proteins of the
distal tubule and collecting duct, the expression and cellular
distribution of NKCC2, -ENaC, -ENaC, -ENaC, -NKA,
and AQP2 were evaluated (Table 3). Western blot quantifica-
tions were performed in cortical or medullary extracts of the
plasma membrane in analogy to the BBM fractions, since it
was assumed that the abundance of these transporters at their
site of action indicates their activation.
Negative results were obtained with NKCC2 and -NKA.
Cortical and medullary parts of TAL segments showed no
Fig. 1. Systolic blood pressure measurements. Values were significantly in-
creased in control megalin knockout/glomerulonephritis [Cre()/GN] and
conditional megalin knockout//glomerulonephritis [Cre()/GN] mice. The
respective numerical values are shown in Table 1. Values are means SE, n
6. *P 
 0.05 for Cre() vs. Cre(). #P 
 0.05 for control vs. GN.
Fig. 2. Urinary vitamin D binding protein (DBP) excretion. A: Western blot
analysis of urinary DBP excretion. Cre() show higher levels than Cre().
Cre()/GN and Cre()/GN show markedly elevated levels compared with
their respective controls. B: densitometric analysis of Western blots. Values are
means  SE, n  6. *P 
 0.05 Cre() vs. Cre(). #P 
 0.05 control vs. GN.
Table 2. COX-2, renin, and plasma aldosterone concentration
Cre() Cre() Cre()/GN Cre()/GN
COX-2/glomerulus, % 100.0014.23 80.1920.91 114.667.13 91.9816.42
Renin/glomerulus, % 100.009.44 93.509.13 79.126.22 75.211.61
Aldosterone, pg/ml 535.17175.16 250.7348.36 248.42109.80 629.47145.60
Values are means  SE. COX-2, cyclooxygenase 2. Immunohistochemical evaluation of tissue cyclooxygenase-2 (COX-2) and renin signals, and radioactive
measurements of plasma aldosterone concentration are summarized in Table 3. No significant differences were observed.
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changes among all groups in NKCC2 plasma membrane abun-
dance, and neither was total -NKA altered in cortex or
medulla (Table 3). In contrast, -ENaC and -ENaC showed
significant, selective enhancements not of their major, charac-
teristic full-length bands, but of additional, lower molecular
weight bands, which probably represented cleavage products
of these ENaC subunits.
At steady state, the additional bands at 55 and 30 kDa
were 3.74- and 1.26-fold enhanced for cortical -ENaC in
Cre() compared with Cre(), suggesting that the absence of
megalin and lack of proximal RME had led to a higher distal
yield of filtered plasma components possibly acting on ENaC
structure (Fig. 5B). Similarly, but less pronounced, an addi-
tional band for cortical -ENaC at 70 kDa was selectively
stronger in Cre() (Fig. 5B). Additional -ENaC bands in the
medulla were enhanced as well (Fig. 5C). There were no
changes in allover -ENaC or medullary -ENaC expression
(Table 3).
In GN, the 55- and 30-kDa band densities for cortical
-ENaC were 5.08- and 1.51-fold enhanced in Cre()/GN and
7.44- and 1.89-fold in Cre()/GN, respectively (Fig. 5B). For
medullary -ENaC, the 55- and 30-kDa band densities were
3.5- and 1.75-fold increased in Cre()/GN and 4.79- and
2.0-fold increased in Cre()/GN, respectively (Fig. 5C). These
results thus further underline the impact of endocytosis on
nephritis-grade distal tubular proteinuria and its possible mod-
ification of -ENaC. Cortical -ENaC was also showing in-
creases in the 70- and 55-kDa bands in GN, but the effects of
endocytosis were not detectable [70 kDa: 2-fold increases in
Cre()/GN and 2.2-fold in Cre()/GN; 55 kDa: 4.1- and
4.31-fold increases each in Cre()/GN and Cre()/GN].
Again, there were no changes in the medulla for -ENaC or in
total -ENaC expression (Table 3).
Expressed as total densities of the full-length and lower
molecular weight bands, compared with Cre() the increases
in Cre(), Cre()/GN, and Cre()/GN were 4.16-, 4.76-, and
8.49-fold for cortical -ENaC and 1.57-, 4.1-, and 5.76-fold for
Fig. 3. Immunohistochemical staining of proximal tubular Na/H exchanger 3 (NHE3), Na-Pi cotransporter IIa (Na-Pi IIa), and aquaporin-1 (AQP1).
Respective double labeling with anti-megalin is indicated by inverted comma (A, B, E, F, I, K). In control conditions, there are no changes for NHE3, whereas
NaPi-IIa and AQP1 show increased BBM staining in megalin-deficient cells. (C, D, G, H, L, M). In GN, NHE3 staining is generally unaltered, whereas NaPi-IIa
and AQP1 BBM staining is diminished. Six mice have been evaluated per group. Bars  20 m.
Fig. 4. NHE3 activity. NHE3 activity is expressed as variations in vesicular
pH measured by the acridine orange quenching method. Filled bars, total NHE
activity; open bars, specific NHE3 activity. In controls, total brush border
membrane (BBM) NHE activity equaled specific NHE3 activity. In GN, NHE3
activity is strongly reduced in both groups. Values are means  SE; n  6.
#P 
 0.05 control vs. GN.
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medullary -ENaC, respectively (each P 
 0.05; Table 3),
displaying significant increases also between Cre()/GN and
Cre()/GN (P 
 0.05). For cortical -ENaC, increases were
3.0-, 4.1-, and 4.31-fold in Cre(), Cre()/GN, and Cre()/
GN, respectively (P 
 0.05; Table 3), but differences between
Cre()/GN and Cre()/GN were not significant. Together,
total density values indicate increased abundances of ENaC
subunits in distal membranes as a function of different grades
of proteinuria.
The signals for AQP2 were strongly diminished in the cortex
but not the medulla of Cre()/GN and Cre()/GN (Fig. 5B;
Table 3).
These findings were roughly paralleled by changes regis-
tered in the immunohistochemical staining series (Fig. 6). The
adluminal staining for cortical collecting duct -ENaC and
-ENaC was increased in Cre() compared with Cre().
Cortical -NKA and AQP2 signals were not markedly differ-
ent between Cre() and Cre(). In GN, Cre() showed
stronger adluminal ENaC signals than Cre(). -NKA signals
showed massive increases in GN; this differed from the West-
ern blot analysis (Table 3), representing a mixture of all
segments so that -NKA changes in the collecting ducts were
probably masked. AQP2 signals were diminished in the GN
groups.
DISCUSSION
This study adds new insights to the discussion of whether
primary, kidney-based salt and water retention, or other, sys-
Fig. 5. Semiquantitative immunoblotting of altered sodium transporters and
water channels along the nephron. A: proximal tubular BBM abundance of
NHE3, NaPi-IIa, and AQP1. B: cortical plasma membrane abundance of
-epithelial Na channel (ENaC), -ENaC, and AQP2. The major (full-length)
bands of - and -ENaC as well as the smaller bands (putative cleavage
products) are demonstrated. For AQP2, two major bands at 29 and 35 kDa are
shown. C: medullary plasma membrane abundance of -ENaC major and
minor bands. All Western blots are representative results from 6 mice per
group. Calculations of Western blot analysis are summarized in Table 3.
Table 3. Protein abundances (Western blotting)
Calculations of Total Protein Abundance  SE
Cre() Cre() Cre()/GN Cre()/GN
BBM fraction
NHE3 1.000.30 1.200.31 1.260.35 1.170.40
NaPi-IIa 1.000.53 2.190.29* 0.410.20 0.890.23†
AQP1 1.000.08 1.300.04* 0.650.10† 0.810.07†
Cortical PM fraction
NKCC2 1.000.17 1.060.17 0.770.06 0.870.10
-ENaC 90 kDa 1.000.08 1.160.16 1.170.05 1.220.13
-ENaC 55 kDa 1.000.23 3.740.82* 5.080.11† 7.440.95*†
-ENaC 30 kDa 1.000.08 1.260.02* 1.510.09† 1.830.07*†
-ENaC 1.000.19 0.880.23 0.940.18 0.890.26
-ENaC 85 kDa 1.000.01 0.970.09 1.090.04 1.030.12
-ENaC 70 kDa 1.000.20 1.620.16* 2.000.12† 2.220.08†
-ENaC 55 kDa 1.000.13 1.410.50 3.010.17† 3.080.37†
-Na-K-ATPase 1.000.25 1.060.18 1.090.17 0.960.20
AQP2 1.000.21 0.930.09 0.330.03† 0.350.08†
Medullary PM fraction
NKCC2 1.000.40 0.860.17 1.760.37 1.340.24
-ENaC 90 kDa 1.000.06 0.900.05 0.850.04 0.940.14
-ENaC 55 kDa 1.000.10 1.410.10* 3.500.10† 4.790.15*†
-ENaC 30 kDa 1.000.06 1.260.08* 1.750.05† 2.030.06*†
-ENaC 1.000.10 1.050.09 0.940.25 1.500.35
-ENaC 85 kDa 1.000.09 1.030.12 0.990.16 1.020.12
-ENaC 70 kDa 1.000.23 1.060.04 1.100.11 1.180.03
-ENaC 55 kDa 1.000.17 1.100.12 1.170.13 1.180.13
-Na-K-ATPase 1.000.11 1.370.14 1.250.22 0.950.17
AQP2 1.000.08 0.940.05 0.880.12 0.850.08
Values are means  SE of densitometric intensity levels normalized to
-actin with Cre() set as 1  100%; n  6. BBM, brush border membrane;
NHE3, Na/H exchanger 3; NaPi-IIa, Na-Pi cotransporter IIa; ENaC,
epithelial Na channel; AQP, aquaporin; PM, plasma membrane. Sources were
BBM and PM. *P 
 0.05 Cre() vs. Cre(). †P 
 0.05 control vs. GN.
Table 4. mRNA abundances of NHE3, NaPi-IIa, and AQP1
Calculations of Total mRNA Abundance  SE
Cre() Cre() Cre()/GN Cre()/GN
NHE3 1.000.11 0.990.23 0.950.23 1.160.10
NaPi-IIa 1.000.03 1.260.16 0.360.05* 0.480.09*
AQP1 1.000.11 1.050.18 0.350.14* 0.390.07*
Values are means  SE; n  6. Control levels Cre() are set as 1  100%.
*P 
 0.05 Cre() vs. Cre().
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temic causes prevail in the volume disorders accompanying
heavy proteinuria. Our results have demonstrated that the
blunted proximal RME and resulting mild proteinuria as well
as the GN-induced glomerular proteinuria with or without
proximal RME had little impact on proximal tubular membrane
transporters with respect to volume retention. No changes were
encountered in the loop of Henle. In contrast, both measures
have caused major, in part additive, changes in surface expres-
sion and molecular weight shifts of ENaC subunits suggestive
of channel activation and potential salt retention. Significant
increases in blood pressure, decreased fractional sodium ex-
cretion, and increased plasma cholesterol levels were estab-
lished in the GN groups. By stabilizing proteinuria within
limits of 10–15 mg/24 h in these groups, we could avoid
changes in GFR which occur with progressive glomerular and
tubulointerstitial damage in the megalin-deficient group (22,
51) so that parameters related to sodium handling were com-
parable among groups.
With the bulk of sodium reabsorption occurring in the
proximal tubule, this segment has been considered to effi-
ciently contribute to volume retention as reported from a rat
study with experimental nephrosis (7). Proximal tubular NHE3
is responsible for virtually all the local Na/H exchange
activity; it is the most effective proximal sodium transporter
and furthermore plays a role in RME by its capacity to acidify
endosomes for proper receptor-ligand dissociation (23). NHE3
activity can be estimated by its biosynthesis rate, its capacity to
redistribute along the BBM microvilli (55), and its acidification
capacity in BBM vesicles; the latter can also be used to
measure its general activity (12). In our study, however, NHE3
failed to reveal major changes in these parameters except for
the decrease in NHE3-specific BBM vesicular acidification in
the GN groups. The decrease, however, appeared to be bal-
anced by another, EIPA-resistant NHE isoform so that there
was no general deficit in acidification of BBM vesicles. We
therefore conclude that expression and activity of NHE3 were
not megalin dependent and showed no changes with reduced
RME. The drastic reduction of the proximal endosomal and
recycling apparatus which otherwise influences NaPi-IIa re-
trieval (4) therefore does not seem to affect NHE3 expression.
The two other products of proximal BBM, NaPi-IIa and
AQP1, showed similar results. Megalin deficiency per se
caused a reduced retrieval of these products, leading to their
increased abundance in BBM, which is consistent with earlier
findings on NaPi-IIa expression (4). The GN groups showed
decreased NaPi-IIa and AQP1 abundance and transcription
rate, with immunoreactive signals equally reduced in megalin-
positive and megalin-deficient proximal epithelia in the mega-
lin-deficient group. These results partly agree with previous
Table 5. Summary of changes in proximal tubule transporter
and channel parameters
Cre() Cre()/GN Cre()/GN
NHE3
IHC 7 7 7
Western blot
BBM 7 7 7
mRNA in cortex 7 7 7
Activity in
BBM 7 2 2
NaPi-IIa, AQP1
IHC 1 2 7(2vs. Cre)
Western blot
BBM 1 2 7(2vs. Cre)
mRNA in cortex 1 2 2
IHC, immunohistochemistry. Vertical arrows indicate significant changes.
All changes refer to Cre() unless indicated separately.
Fig. 6. Immunohistochemical staining of cortical
-ENaC, -ENaC, -Na-K-ATPase (NKA), and
AQP2. A–H: adluminal abundances for -ENaC and
-ENaC are increased in the Cre() controls and in
both GN groups with strongest signals in Cre()/GN.
I–M: basolateral -NKA signals in GN are stronger
than in controls. N–Q: AQP2 signals are diminished in
the GN groups. Six mice have been evaluated per
group. Bars  20 m.
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work in models of nephrotic syndrome or anti-Thy1 GN (22,
33), although the reason for the decreases remains to be
established. Functionally, the decrease in AQP1 and conse-
quent reduction in proximal transcellular water passage may
activate tubuloglomerular feedback, which prevents inadequate
water and NaCl delivery to the distal nephron in AQP1-
deficient mice (45). Feedback activation in nephrosis may be
relevant to stabilize sodium and water delivery to the post-
macula segments (29).
Taken together, neither the abundance nor the activity of
NHE3, NaPi-IIa, and AQP1 in our model is consistent with
proximal tubule-based volume retention in GN and is thus at
variance with data raised in puromycin aminonucleoside ne-
phrosis (7). Along the same line, earlier micropuncture studies
in rats were not supporting a direct role for the proximal tubule
in sodium retention. Studies on experimental anti-GBM ne-
phritis demonstrated equal fractional reabsorption of the prox-
imal tubule in controls and anti-GBM treated rats (46), and rats
with unilateral nephrosis showed reduced sodium reabsorption
in proximal convoluted tubule and thick ascending limb (29).
The absence of changes in juxtaglomerular COX-2 (50) and
RAAS parameters further underlines our conclusion and is
partly consistent with previous work (8, 16, 22, 46).
The most striking results of this study are related to the
collecting duct system. In megalin-deficient controls as well as
in both GN groups alike, the plasma membrane abundances of
-ENaC and -ENaC revealed by Western blotting (sum of
band densities) and immunohistochemistry were enhanced,
suggesting that despite the major quantitative differences in
urinary protein levels, decreased proximal RME and resulting
tubular proteinuria as well as glomerular proteinuria were both
producing similar changes in the adluminal collecting duct cell
compartment. The reason for these trafficking events in the
absence of RAAS changes is not clear. In nephrotic syndrome,
an influence of altered tubular protein composition on the
intracellular trafficking machinery in the absence of mineralo-
corticoid changes has been considered (3). The absence of
changes in -ENaC parallels other work on disproportionate
changes of ENaC subunits in nephrosis, suggesting that -ENaC is
less involved in regulatory events (22, 32, 39).
The increased Western blot abundances of ENaC subunits in
the membrane fractions were characterized by selective en-
hancements of the smaller 55- and 30-kDa bands for the
-subunit and 70 kDa for the -subunit in the cortex of
megalin-deficient mice, whereas the full-length bands were not
altered. These increases were more pronounced in the GN
groups, chiefly for -ENaC, which also showed enhanced
medullary signals of the smaller bands. RME deficiency pro-
duced additive changes. Increases in the 70-kDa -ENaC
bands in GN were restricted to the cortex and also revealed
changes in a second 55-kDa band; both bands showed no
further changes with reduced RME.
These results may be important in light of recent findings
suggesting that ENaC electrophoretic shifts occur upon enzy-
matic cleavage of its subunits and that these changes are
consistent with an activation of the channel (5, 25, 28, 44). This
mechanism has been illustrated by the observation that amilo-
ride-sensitive sodium currents are increased in response to
extracellular serine protease (52), and exogenously added tryp-
sin and resident proteases had similar effects (5, 25, 28).
Inhibitory tracts of ENaC subunits, that can be liberated by
proteolysis, have further been identified (13). Proteases such as
plasmin, which could be obtained from the urine of nephrotic
rats, were shown to activate ENaC (43, 48). Plasmin may be
locally activated from filtered plasminogen and appears to be
particularly effective in full-channel activation by proteolytic
processing of -ENaC (43). Passage of plasma proteases
through the leaky glomerular filter in GN has been established,
so that a similar mechanism of ENaC proteolysis and activation
may be operative in our GN model. In the rat, we previously
had obtained similar results in anti-Thy1 GN, with -ENaC
revealing an additional 65-kDa band typical of furin cleavage
(22, 28). While the size of the present 70-kDa -ENaC cleav-
age product corresponds to published evidence (43), increases
in -ENaC bands were ranging at somewhat divergent molec-
ular weight ranges compared with previous data. The larger
55-kDa band may be regarded as mildly divergent but analo-
gous to otherwise shown 60- to 65-kDa ranges (22). The
30-kDa band suggests that the minor NH2-terminal extracellu-
lar domain (and not the long 60-kDa major portion) of the
cleaved protein was recognized, since our antibody was di-
rected to an NH2-terminal fusion protein and not to the COOH-
terminally tagged recognition sites used by other groups; this
agrees with previous data obtained with the NH2-terminally
directed antibody which recognized the 30-kDa band as well
(19, 21, 44). The 30-kDa fragment also reflects furin (or other
protease)-dependent cleavage under stimulated condition in a
heterologous system (28). It may further be considered that the
occurrence of the 55-kDa ranges for - and -ENaC products
could be related to immature or degraded glycosylation, pos-
sibly resulting from insufficient intracellular processing, or via
the action of filtered glycosidases or locally activated degly-
cosylation (19). The concept of ENaC activation by proteolytic
cleavage is thus indirectly supported by our results in GN-
associated proteinuria. Loss of proximal RME per se was
associated with marked increases in ENaC cleavage products,
suggesting that the relevant proteases are ligands of megalin.
Data further support, at least for -ENaC, that depending on
the extent of proteinuria and ensuing proximal saturation of
RME, megalin may thus indirectly affect downstream sodium
handling.
Our data thus support a role of the collecting duct system as
the crucial site in the nephron for sodium retention in protein-
uric nephropathy which agrees with earlier work (11, 29, 32,
33, 38, 46). Apart from the presumed role for ENaC, primary,
aldosterone-independent involvement of NKA in distal sodium
retention has further been discussed (7, 38). It must, however,
be considered that an ENaC-mediated rise in intracellular
sodium concentration may also per se adjust the activity of
NKA (9). The observed immunohistochemical upregulation of
collecting duct -NKA would therefore agree with activated
transport secondary to a rise in ENaC-mediated intracellular
sodium concentration (38).
The marked decreases in AQP2 abundance in the GN groups
also reflect earlier data from models of the nephrotic syndrome
(20) and could represent a physiologically appropriate response
to extracellular volume expansion. AQP2 may act indepen-
dently of plasma vasopressin levels, which tend to be normal or
elevated in these models (2, 19).
Since lipiduria is a frequent phenomenon in proteinuric
disease and plasma cholesterol was enhanced in our model,
altered membrane lipids may further be related to the observed
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changes. Cellular fatty acids may cause cell dysfunction, and
mice loaded with fatty acid and BSA exhibited systemic water
retention (31) so that altered transepithelial reabsorption of
sodium and water in the present model may be related to these
changes. Since NaPi-IIa, NHE3, and aquaporins have been
shown to be lipid raft associated, trafficking or membrane
association of these proteins may be impaired in an altered
cholesterol environment (10, 14, 30, 37, 41, 56). This may
apply as well to distal epithelia, where NKA (53), NKCC2
(54), and ENaC (26) were shown to be partially lipid raft
dependent, albeit with heterogenous functional consequences
which are not entirely understood at present.
In sum, our study has identified renal changes in anti-GBM
nephritis which may be relevant for volume retention, hyper-
tension, and edema formation in human GN or nephritic
syndrome. Our model suggests that in GN, altered filtrate
composition as well as proximal tubular RME, controlled by
megalin, are major determinants for renal-based salt retention
and volume expansion. Whereas proximal tubular membrane
transporters do not seem to be causally involved herein, struc-
tural changes in - and -ENaC subunits, probably caused by
proteolytic cleavage via filtered plasma proteases, as well as
their enhanced membrane abundances may determine collect-
ing duct-based sodium retention. Although tubular and glomer-
ular proteinuria may produce analogous effects on sodium
handling within distal epithelia, the effects of glomerular
proteinuria clearly dominated those of blunted proximal endo-
cytosis in contributing to ENaC cleavage and antinatriuresis.
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